Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P00540: Variant p.His199Leu

Proto-oncogene serine/threonine-protein kinase mos
Gene: MOS
Feedback?
Variant information Variant position: help 199 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Histidine (H) to Leucine (L) at position 199 (H199L, p.His199Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (H) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In OZEMA20; likely pathogenic; loss of function in oocyte maturation activation; loss of activation of the ERK1/ERK2 cascade; no effect on localization to cytoplasm. Any additional useful information about the variant.


Sequence information Variant position: help 199 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 346 The length of the canonical sequence.
Location on the sequence: help LKYSLDVVNGLLFLHSQSIV H LDLKPANILISEQDVCKISD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         LKYSLDVVNGLLFLHSQSIVHLDLKPANILISEQDVCKISD

Mouse                         LKYSLDVVNGLLFLHSQSILHLDLKPANILISEQDVCKISD

Rat                           LKYSLDIVNGLLFLHSQSILHLDLKPANILISEKDVCKISD

Pig                           LKYSLDVVSGLLFLHSQGIVHLDLKPANILISEQDVCKISD

Chicken                       VCYSCDIVTGLAFLHSQGIVHLDLKPANILITEHGACKIGD

Xenopus laevis                MRYARHVADGLRFLHRDGVVHLDLKPANVLLAPGDLCKIGD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 346 Proto-oncogene serine/threonine-protein kinase mos
Domain 60 – 341 Protein kinase
Active site 201 – 201 Proton acceptor



Literature citations
Biallelic variants in MOS cause large polar body in oocyte and human female infertility.
Zhang Y.L.; Zheng W.; Ren P.; Jin J.; Hu Z.; Liu Q.; Fan H.Y.; Gong F.; Lu G.X.; Lin G.; Zhang S.; Tong X.;
Hum. Reprod. 37:1932-1944(2022)
Cited for: VARIANTS OZEMA20 LEU-199; CYS-264 AND VAL-292; CHARACTERIZATION LEU-199; CYS-264 AND VAL-292; FUNCTION; SUBCELLULAR LOCATION; INTERACTION WITH MAP2K1;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.